申请人:John Wyeth and Brother Limited
公开号:US04325953A1
公开(公告)日:1982-04-20
4-Aryl-4-aryloxypiperidines of the general formula (I) ##STR1## and their pharmaceutically acceptable acid addition salts, wherein R.sup.1 and R.sup.2 are hydrogen or lower alkyl, R.sup.3 is hydrogen, lower alkyl or benzyl, Ar is phenyl optionally substituted by one or more halogen, trifluoromethyl, lower alkyl, lower alkoxy, nitro or amino groups and Ar.sup.1 is a phenyl radical optionally substituted by one or more cyano, methylsulphinyl, methylsulphonyl, lower alkoxy, trifluoromethyl, lower alkyl, lower alkenyl, halogen, nitro, amino or acylamino groups or an aromatic heterocyclic mono- or di-cyclic radical, exhibit activity on the central nervous system, e.g. as antidepressants.
通用式(I)的4-芳基-4-芳氧基哌啶及其药学上可接受的酸盐,其中R.sup.1和R.sup.2是氢或较低的烷基,R.sup.3是氢、较低的烷基或苄基,Ar是苯基,可选择地被一个或多个卤素、三氟甲基、较低的烷基、较低的烷氧基、硝基或氨基取代,Ar.sup.1是一个苯基基团,可选择地被一个或多个氰基、甲磺基、磺酰基甲基、较低的烷氧基、三氟甲基、较低的烷基、较低的烯基、卤素、硝基、氨基或酰胺基团或芳香族杂环单环或双环基团取代,表现出对中枢神经系统的活性,例如作为抗抑郁药。